Comments
Loading...
Pulmonx Analyst Ratings and Price Targets | NASDAQ:LUNG | Benzinga
Pulmonx Corp has a consensus price target of $12.77 based on the ratings of 11 analysts. The high is $18 issued by Craig-Hallum on September 5, 2023. The low is $7.5 issued by Citigroup on December 11, 2024. The 3 most-recent analyst ratings were released by D. Boral Capital, D. Boral Capital, and Wells Fargo on March 11, 2025, March 10, 2025, and December 11, 2024, respectively. With an average price target of $14 between D. Boral Capital, D. Boral Capital, and Wells Fargo, there's an implied 161.10% upside for Pulmonx Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
Wells Fargo
Citigroup
Stifel
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Pulmonx
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/11/2025 | Buy Now | 217.05% | D. Boral Capital | Jason Kolbert38% | $17 → $17 | Maintains | Buy | Get Alert |
| 03/10/2025 | Buy Now | 217.05% | D. Boral Capital | Jason Kolbert38% | → $17 | Initiates | → Buy | Get Alert |
| 12/11/2024 | Buy Now | 49.2% | Wells Fargo | Larry Biegelsen67% | $10 → $8 | Maintains | Equal-Weight | Get Alert |
| 12/11/2024 | Buy Now | 39.87% | Citigroup | Joanne Wuensch75% | $17 → $7.5 | Downgrade | Buy → Neutral | Get Alert |
| 10/31/2024 | Buy Now | 198.4% | Stifel | Rick Wise73% | $17 → $16 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | 123.8% | Piper Sandler | Jason Bednar52% | $14 → $12 | Maintains | Overweight | Get Alert |
| 08/01/2024 | Buy Now | 198.4% | Canaccord Genuity | Jon Young44% | $15 → $16 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | 86.5% | Wells Fargo | Larry Biegelsen67% | $14 → $10 | Maintains | Equal-Weight | Get Alert |
| 06/04/2024 | Buy Now | 123.8% | Lake Street | Frank Takkinen35% | → $12 | Initiates | → Buy | Get Alert |
| 05/02/2024 | Buy Now | 179.75% | Canaccord Genuity | Jon Young44% | $16 → $15 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 217.05% | Piper Sandler | Jason Bednar52% | $17 → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | Buy Now | 217.05% | Citigroup | Joanne Wuensch75% | $16 → $17 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 161.1% | Wells Fargo | Larry Biegelsen67% | $16 → $14 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/22/2024 | Buy Now | 217.05% | Stifel | Rick Wise73% | $15 → $17 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | 217.05% | Piper Sandler | Jason Bednar52% | $13 → $17 | Maintains | Overweight | Get Alert |
| 02/22/2024 | Buy Now | 198.4% | Wells Fargo | Larry Biegelsen67% | $15 → $16 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | 142.45% | Piper Sandler | Jason Bednar52% | $17 → $13 | Maintains | Overweight | Get Alert |
| 10/31/2023 | Buy Now | 123.8% | Canaccord Genuity | William Plovanic53% | $20 → $12 | Maintains | Buy | Get Alert |
| 09/05/2023 | Buy Now | 235.7% | Craig-Hallum | Alexander Nowak54% | → $18 | Initiates | → Buy | Get Alert |
| 08/03/2023 | Buy Now | 217.05% | Piper Sandler | Jason Bednar52% | $15 → $17 | Maintains | Overweight | Get Alert |
| 07/11/2023 | Buy Now | 198.4% | Citigroup | Joanne Wuensch75% | $14 → $16 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 161.1% | Citigroup | Joanne Wuensch75% | $13 → $14 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 179.75% | Piper Sandler | Jason Bednar52% | $13 → $15 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | 161.1% | Morgan Stanley | Cecilia Furlong51% | $11 → $14 | Maintains | Equal-Weight | Get Alert |
| 04/03/2023 | Buy Now | 142.45% | Citigroup | Joanne Wuensch75% | $12 → $13 | Maintains | Buy | Get Alert |
| 02/27/2023 | Buy Now | 179.75% | Wells Fargo | Larry Biegelsen67% | $10 → $15 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/24/2023 | Buy Now | 123.8% | Citigroup | Joanne Wuensch75% | $10 → $12 | Maintains | Buy | Get Alert |
| 02/23/2023 | Buy Now | 273% | Canaccord Genuity | William Plovanic53% | $18 → $20 | Maintains | Buy | Get Alert |
| 02/23/2023 | Buy Now | 105.15% | Morgan Stanley | Cecilia Furlong51% | $9.5 → $11 | Maintains | Equal-Weight | Get Alert |
| 01/06/2023 | Buy Now | 77.17% | Morgan Stanley | Cecilia Furlong51% | $14 → $9.5 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | Buy Now | 49.2% | B of A Securities | Travis Steed59% | → $8 | Downgrade | Neutral → Underperform | Get Alert |
| 12/12/2022 | Buy Now | 11.9% | Wells Fargo | Larry Biegelsen67% | $13.5 → $6 | Maintains | Equal-Weight | Get Alert |
| 12/12/2022 | Buy Now | 86.5% | Citigroup | Joanne Wuensch75% | $14 → $10 | Upgrade | Neutral → Buy | Get Alert |
| 11/07/2022 | Buy Now | 161.1% | Morgan Stanley | Cecilia Furlong51% | $19 → $14 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | 142.45% | Piper Sandler | Jason Bednar52% | $25 → $13 | Maintains | Overweight | Get Alert |
| 10/11/2022 | Buy Now | 254.35% | Morgan Stanley | Cecilia Furlong51% | $21 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | 291.64% | Morgan Stanley | Cecilia Furlong51% | $19 → $21 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 366.24% | Piper Sandler | Jason Bednar52% | $37 → $25 | Maintains | Overweight | Get Alert |
| 07/18/2022 | Buy Now | 273% | Stifel | Rick Wise73% | $32 → $20 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 254.35% | Morgan Stanley | Cecilia Furlong51% | $30 → $19 | Maintains | Equal-Weight | Get Alert |
| 07/11/2022 | Buy Now | 254.35% | Citigroup | Joanne Wuensch75% | $23 → $19 | Downgrade | Buy → Neutral | Get Alert |
| 05/17/2022 | Buy Now | 328.94% | Citigroup | Joanne Wuensch75% | $32 → $23 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Pulmonx (LUNG) stock?
The latest price target for Pulmonx (NASDAQ:LUNG) was reported by D. Boral Capital on March 11, 2025. The analyst firm set a price target for $17.00 expecting LUNG to rise to within 12 months (a possible 217.05% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pulmonx (LUNG)?
The latest analyst rating for Pulmonx (NASDAQ:LUNG) was provided by D. Boral Capital, and Pulmonx maintained their buy rating.
When was the last upgrade for Pulmonx (LUNG)?
The last upgrade for Pulmonx Corp happened on February 27, 2023 when Wells Fargo raised their price target to $15. Wells Fargo previously had an equal-weight for Pulmonx Corp.
When was the last downgrade for Pulmonx (LUNG)?
The last downgrade for Pulmonx Corp happened on December 11, 2024 when Citigroup changed their price target from $17 to $7.5 for Pulmonx Corp.
When is the next analyst rating going to be posted or updated for Pulmonx (LUNG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pulmonx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pulmonx was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.
Is the Analyst Rating Pulmonx (LUNG) correct?
While ratings are subjective and will change, the latest Pulmonx (LUNG) rating was a maintained with a price target of $17.00 to $17.00. The current price Pulmonx (LUNG) is trading at is $5.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.